Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

APTX

Aptinyx (APTX)

Aptinyx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APTX
DateTimeSourceHeadlineSymbolCompany
12/21/202310:52AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTXAptinyx Inc
06/27/20232:14PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
05/24/20234:50PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
05/24/20234:44PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
05/24/20234:44PMEdgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:APTXAptinyx Inc
05/24/20234:40PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
05/24/20234:40PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
05/23/20238:26AMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:APTXAptinyx Inc
05/15/20234:46PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:APTXAptinyx Inc
05/11/20238:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
05/05/20238:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
04/28/20234:19PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:APTXAptinyx Inc
04/25/20239:24AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
03/30/20234:31PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:APTXAptinyx Inc
03/30/20234:05PMBusiness WireAptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic AlternativesNASDAQ:APTXAptinyx Inc
03/16/20234:20PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
03/01/20238:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
02/27/20234:03PMBusiness WireAptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate UpdateNASDAQ:APTXAptinyx Inc
02/14/20234:49PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
01/31/20237:47AMBusiness WireAptinyx to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:APTXAptinyx Inc
01/05/20234:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTXAptinyx Inc
01/05/20234:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTXAptinyx Inc
12/12/20226:25AMTipRanksH.C. Wainwright Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
12/08/20224:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
12/01/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
11/10/20227:45AMBusiness WirePreclinical Data from Aptinyx’s NMDA Receptor Modulators to be Presented at the 52nd Annual Meeting of the Society for NeuroscienceNASDAQ:APTXAptinyx Inc
11/09/202211:26PMTipRanksSVB Securities Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
11/09/202210:16AMTipRanksBMO Capital Remains a Buy on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
11/08/20224:32PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APTXAptinyx Inc
11/08/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
 Showing the most relevant articles for your search:NASDAQ:APTX